Correspondence 0001104659-22-131444 from HH&L Acquisition Co. (CIK 0001824185)
HH&L Acquisition Co. (CIK 0001824185)
Date: Dec. 30, 2022 · CIK: 0001824185 · Accession: 0001104659-22-131444
AI Filing Summary & Sentiment
File numbers found in text: 001-40006
Referenced dates: December 28, 2022
Show Raw Text
CORRESP
1
filename1.htm
December 30, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, NE
Washington, D.C. 20549
Attn: Margaret Schwartz
Celeste Murphy
Re: HH&L Acquisition Co.
Preliminary Proxy on Schedule 14A
Filed December 23, 2022
File No. 001-40006
Dear Ms. Schwartz and Ms. Murphy:
On behalf of our client, HH&L
Acquisition Co., a Cayman Islands exempted company (the “Company”), we are writing to submit the Company’s responses
to the comments of the staff of the Division of Corporation Finance of the United States Securities and Exchange Commission (the “Staff”)
with respect to the above-referenced preliminary proxy on schedule 14A (the “Preliminary Proxy Statement”) filed on
December 23, 2022, contained in the Staff’s letter dated December 28, 2022 (the “Comment Letter”) and received
during a phone call held with members of the Staff on the same date.
Concurrently with the submission
of this letter, the Company has filed via EDGAR its Amendment No.1 to the Preliminary Proxy Statement (the “Revised Proxy Statement”).
For ease of reference, each comment received is printed below in bold and is followed by the Company’s response. All page references
in the responses set forth below refer to page numbers in the Revised Proxy Statement. Capitalized terms used but not defined herein have
the meanings set forth in the Revised Proxy Statement.
Preliminary Proxy on Schedule
14A filed December 23, 2022
General
1. With a view toward disclosure, please tell us whether your sponsor is, is controlled by, has any members
who are, or has substantial ties with, a non-U.S. person. If so, please revise your filing to include risk factor disclosure that addresses
how this fact could impact your ability to complete your initial business combination. For instance, discuss the risk to investors that
you may not be able to complete an initial business combination with a target company should the transaction be subject to review by a
U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Disclose that
as a result, the pool of potential targets with which you could complete an initial business combination may be limited. Further, disclose
that the time necessary for government review of the transaction or a decision to prohibit the transaction could prevent you from completing
an initial business combination and require you to liquidate. Disclose the consequences of liquidation to investors, such as the losses
of the investment opportunity in a target company, any price appreciation in the combined company, and the warrants, which would expire
worthless.
RESPONSE:
In response to the
Staff’s comment, the Company has added disclosure on pages 19 to 20 of the Revised Proxy Statement.
United States Securities and Exchange Commission
December 30, 2022
In addition, in response to the
Staff’s oral comments, the Company has revised the disclosure (i) on pages 7 and 30 of the Revised Proxy Statement with
respect to the timing of the Company’s plan to transfer the assets in the trust account to a bank deposit account, (ii) on
page 21 of the Revised Proxy Statement to disclose the consequences of liquidation to the public investors, and (iii) on pages 14 and 20 of Revised Proxy Statement to clarify the reasons why the Company decided to move the trust
account assets into cash.
* * * * * *
2
United States Securities and Exchange Commission
December 30, 2022
Please do not hesitate to
contact Joel L. Rubinstein at (212) 819-764 White & Case LLP with any questions or comments regarding this letter.
Sincerely,
/s/ White & Case LLP
White & Case LLP
cc:
Richard Qi Li, HH&L
Acquisition Co.
Mitchell S. Nussbaum, Loeb &
Loeb LLP
Janeane R. Ferrari, Loeb &
Loeb LLP
3